These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 12198649

  • 1. Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury.
    Yagnik GP, Takahashi Y, Tsoulfas G, Reid K, Murase N, Geller DA.
    Hepatology; 2002 Sep; 36(3):573-81. PubMed ID: 12198649
    [Abstract] [Full Text] [Related]

  • 2. Liver I/R injury is improved by the arginase inhibitor, N(omega)-hydroxy-nor-L-arginine (nor-NOHA).
    Reid KM, Tsung A, Kaizu T, Jeyabalan G, Ikeda A, Shao L, Wu G, Murase N, Geller DA.
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G512-7. PubMed ID: 17023552
    [Abstract] [Full Text] [Related]

  • 3. Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation.
    Geller DA, Chia SH, Takahashi Y, Yagnik GP, Tsoulfas G, Murase N.
    JPEN J Parenter Enteral Nutr; 2001 Feb; 25(3):142-7. PubMed ID: 11334063
    [Abstract] [Full Text] [Related]

  • 4. The effects of administration of nitric oxide inhibitors during small bowel preservation and reperfusion.
    Mueller AR, Platz KP, Langrehr JM, Hoffman RA, Nussler AK, Nalesnik M, Billiar TR, Schraut WH.
    Transplantation; 1994 Dec 27; 58(12):1309-16. PubMed ID: 7809922
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.
    Kozlov AV, Sobhian B, Duvigneau JC, Costantino G, Gemeiner M, Nohl H, Redl H, Bahrami S.
    J Lab Clin Med; 2002 Nov 27; 140(5):303-11. PubMed ID: 12434131
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The effects of nitric oxide on the survival of a random pattern skin flap].
    Du J, Jin J, Zhang S, Tao Z, Cheng A.
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2002 Nov 27; 18(6):353-6. PubMed ID: 12664804
    [Abstract] [Full Text] [Related]

  • 9. Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival.
    Kaizu T, Ikeda A, Nakao A, Takahashi Y, Tsung A, Kohmoto J, Toyokawa H, Shao L, Bucher BT, Tomiyama K, Nalesnik MA, Murase N, Geller DA.
    Hepatology; 2006 Mar 27; 43(3):464-73. PubMed ID: 16496305
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis.
    Gabbai FB, Boggiano C, Peter T, Khang S, Archer C, Gold DP, Kelly CJ.
    J Immunol; 1997 Dec 15; 159(12):6266-75. PubMed ID: 9550431
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide synthase inhibitors modulate lipopolysaccharide-induced hepatocyte injury: dissociation between in vivo and in vitro effects.
    Farghali H, Canová N, Kucera T, Martínek J, Masek K.
    Int Immunopharmacol; 2003 Nov 15; 3(12):1627-38. PubMed ID: 14555288
    [Abstract] [Full Text] [Related]

  • 12. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL, Hon WM, Lee KH, Khoo HE.
    Liver Int; 2005 Jun 15; 25(3):647-56. PubMed ID: 15910502
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Does dietary ornithine alpha-ketoglutarate supplementation protect the liver against ischemia-reperfusion injury?
    Schuster H, Blanc MC, Genthon C, Thérond P, Bonnefont-Rousselot D, Le Tourneau A, De Bandt JP, Cynober L.
    Clin Nutr; 2005 Jun 15; 24(3):375-84. PubMed ID: 15896423
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury.
    Shen J, Ma S, Chan P, Lee W, Fung PC, Cheung RT, Tong Y, Liu KJ.
    J Neurochem; 2006 Feb 15; 96(4):1078-89. PubMed ID: 16417587
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.
    Lukivskaya O, Patsenker E, Lis R, Buko VU.
    Eur J Clin Invest; 2008 May 15; 38(5):317-25. PubMed ID: 18380797
    [Abstract] [Full Text] [Related]

  • 18. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
    Kobara M, Tatsumi T, Takeda M, Mano A, Yamanaka S, Shiraishi J, Keira N, Matoba S, Asayama J, Nakagawa M.
    Basic Res Cardiol; 2003 Sep 15; 98(5):319-28. PubMed ID: 12955405
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide synthase distribution and expression with ischemic preconditioning of the rat liver.
    Koti RS, Tsui J, Lobos E, Yang W, Seifalian AM, Davidson BR.
    FASEB J; 2005 Jul 15; 19(9):1155-7. PubMed ID: 15870170
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide synthase inhibitor increases hepatic injury with formation of oxidative DNA damage and microcirculatory disturbance in endotoxemic rats.
    Takemura S, Minamiyama Y, Inoue M, Kubo S, Hirohashi K, Kinoshita H.
    Hepatogastroenterology; 2000 Jul 15; 47(35):1364-70. PubMed ID: 11100353
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.